Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
Rhea-AI Summary
Tarsus Pharmaceuticals (NASDAQ: TARS) has scheduled its first quarter 2025 financial results announcement and corporate update for Thursday, May 1, 2025. The company will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET. Interested participants can access the webcast through the company's website, where a recorded version will be available shortly after the event and remain accessible for approximately 90 days.
Positive
- None.
Negative
- None.
IRVINE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Thursday, May 1, 2025, to report its first quarter 2025 financial results and provide a corporate update.
Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution)
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com
FAQ
When will Tarsus Pharmaceuticals (TARS) release Q1 2025 earnings?
How can investors access the TARS Q1 2025 earnings call?
How long will the TARS Q1 2025 earnings call recording be available?
What will be discussed in the TARS May 1, 2025 webcast?
